FTXHvsIHEETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. FTXH's top 1 sector exposures are Healthcare. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.37% for IHE. FTXH is up 31.84% year-to-date (YTD) with +$1.02B in YTD flows. IHE performs worse with 23.42% YTD performance, and +$500M in YTD flows. Run a side-by-side ETF comparison of FTXH and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs IHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH IHE | +3.28%+0.57% | +9.09%-0.02% | +31.84%+23.42% | +47.80%+41.86% | +87.39%+94.59% | +77.36%+81.35% |
| Flows | FTXH IHE | +$41M-$124M | +$176M-$62M | +$1.02B+$500M | +$1.02B+$664M | +$1.02B+$614M | +$1.02B+$754M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH IHE | +18.78%+18.52% | +17.62%+18.62% | +17.11%+17.18% | +16.43%+16.77% |
| Max drawdown | FTXH IHE | -5.45%-9.67% | -7.50%-9.67% | -19.32%-16.04% | -19.32%-16.12% |
| Max drawdown duration | FTXH IHE | 57d70d | 99d70d | 393d210d | 393d669d |
Trading data
FTXH | IHE | |
Last sale 10/29/2026 at 1:30 PM | $43.77 | $106.61 |
| Previous close 10/28/2026 | $43.25 | $103.67 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FTXH | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
FTXH | IHE | |
|---|---|---|
| Last price | $43.77 | $106.61 |
| 1D performance | +1.22% | +2.84% |
| AuM | $1.16 B | $1.56 B |
| E/R | 0.6% | 0.37% |
Characteristics
FTXH | IHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | iShares |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 49 | 57 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | May 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
95.82%
Other
4.18%
IHE
USA
95.75%
Other
4.25%
Sectors
FTXH
Healthcare
99.79%
Other
0.21%
IHE
Healthcare
99.75%
Other
0.25%
Advertisement
Diversification
FTXH
Total weight of top 15 holdings out of 15
67.15%
IHE
Total weight of top 15 holdings out of 15
84.42%
Top 15 holdings
Data as of August 31, 2026
FTXH
Merck & Co., Inc.
7.62%
AbbVie, Inc.
7.05%
Eli Lilly & Co.
6.92%
Johnson & Johnson
6.87%
Bristol Myers Squibb Co.
6.75%
Amgen, Inc.
3.56%
Biogen, Inc.
3.54%
Viatris, Inc.
3.51%
Vertex Pharmaceuticals, Inc.
3.48%
Regeneron Pharmaceuticals, Inc.
3.33%
Cardinal Health, Inc.
3.29%
Pfizer Inc.
3.25%
Gilead Sciences, Inc.
3.16%
Incyte Corp.
2.43%
United Therapeutics Corp.
2.39%
IHE
Johnson & Johnson
22.45%
Eli Lilly & Co.
20.50%
Merck & Co., Inc.
5.00%
Bristol Myers Squibb Co.
4.84%
Royalty Pharma Plc
4.54%
Pfizer Inc.
4.48%
Viatris, Inc.
4.19%
Zoetis, Inc.
3.82%
Jazz Pharmaceuticals Plc
3.43%
Elanco Animal Health, Inc.
2.61%
Corcept Therapeutics, Inc.
2.36%
Crinetics Pharmaceuticals, Inc.
1.95%
Axsome Therapeutics, Inc.
1.87%
Ligand Pharmaceuticals, Inc.
1.24%
Definium Therapeutics, Inc.
1.12%
Frequently asked questions about FTXH and IHE
How have the FTXH and IHE ETFs performed in 2026?
As of October 28, 2026, FTXH is up 31.84% year-to-date (YTD), while IHE has returned 23.42%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or IHE?
Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$500M for IHE.
Which ETF is more volatile: FTXH or IHE?
Over the past year, FTXH had a volatility of 17.62%, while IHE experienced 18.62%.
Which ETF is bigger: FTXH or IHE?
As of October 28, 2026, FTXH holds $1.16 B in assets under management (AUM), while IHE manages $1.56 B.
What sectors do the FTXH and IHE ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.
What are the top holdings of the FTXH ETF and IHE ETF?
FTXH top holdings include Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..
Which ETF is more diversified: FTXH or IHE?
FTXH holds 49 securities with 67.15% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.42%.
Advertisement
Latest news about FTXH & IHE
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
